![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
October 14, 2026
This clinical trial explores new treatment approaches for lymphoma that has relapsed after remission or is no longer responding to initial treatment
October 14, 2026
Nine early-career investigators will present their cancer research projects; two will be selected to receive awards of distinction
October 14, 2026
This phase 3 clinical trial is comparing two first-line treatments for multiple myeloma patients not having a stem cell transplant
October 14, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more